Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
NCT05642715Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Apr 2024
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial in human immunodeficiency virus infection (HIV) and Tobacco Use Disorder (TUD) (2 arms), sponsored by Montefiore Medical Center. Primary endpoints: Change in cigarettes smoked per day at 9 months, Occurrence of low-dose CT (LDCT) screening for lung cancer at 9 months and 4 more. Started Apr 2024; status: recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05642715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05642715.